Literature DB >> 27723662

Pedunculopontine Nucleus Region Deep Brain Stimulation in Parkinson Disease: Surgical Anatomy and Terminology.

Clement Hamani1, Tipu Aziz, Bastiaan R Bloem, Peter Brown, Stephan Chabardes, Terry Coyne, Kelly Foote, Edgar Garcia-Rill, Etienne C Hirsch, Andres M Lozano, Paolo A M Mazzone, Michael S Okun, William Hutchison, Peter Silburn, Ludvic Zrinzo, Mesbah Alam, Laurent Goetz, Erlick Pereira, Anand Rughani, Wesley Thevathasan, Elena Moro, Joachim K Krauss.   

Abstract

Several lines of evidence over the last few years have been important in ascertaining that the pedunculopontine nucleus (PPN) region could be considered as a potential target for deep brain stimulation (DBS) to treat freezing and other problems as part of a spectrum of gait disorders in Parkinson disease and other akinetic movement disorders. Since the introduction of PPN DBS, a variety of clinical studies have been published. Most indicate improvements in freezing and falls in patients who are severely affected by these problems. The results across patients, however, have been variable, perhaps reflecting patient selection, heterogeneity in target selection and differences in surgical methodology and stimulation settings. Here we outline both the accumulated knowledge and the domains of uncertainty in surgical anatomy and terminology. Specific topics were assigned to groups of experts, and this work was accumulated and reviewed by the executive committee of the working group. Areas of disagreement were discussed and modified accordingly until a consensus could be reached. We demonstrate that both the anatomy and the functional role of the PPN region need further study. The borders of the PPN and of adjacent nuclei differ when different brainstem atlases and atlas slices are compared. It is difficult to delineate precisely the PPN pars dissipata from the nucleus cuneiformis, as these structures partially overlap. This lack of clarity contributes to the difficulty in targeting and determining the exact localization of the electrodes implanted in patients with akinetic gait disorders. Future clinical studies need to consider these issues.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27723662      PMCID: PMC5298183          DOI: 10.1159/000449010

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  50 in total

1.  Quantification of cholinergic and select non-cholinergic mesopontine neuronal populations in the human brain.

Authors:  K F Manaye; R Zweig; D Wu; L B Hersh; S De Lacalle; C B Saper; D C German
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

Review 2.  Control of sleep and wakefulness by brainstem monoaminergic and cholinergic neurons.

Authors:  Y Kayama; Y Koyama
Journal:  Acta Neurochir Suppl       Date:  2003

3.  Decreased habituation of midlatency auditory evoked responses in Parkinson's disease.

Authors:  C Teo; L Rasco; K al-Mefty; R D Skinner; F A Boop; E Garcia-Rill
Journal:  Mov Disord       Date:  1997-09       Impact factor: 10.338

4.  Excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey.

Authors:  J Kojima; Y Yamaji; M Matsumura; A Nambu; M Inase; H Tokuno; M Takada; H Imai
Journal:  Neurosci Lett       Date:  1997-04-25       Impact factor: 3.046

5.  The brain stem reticular formation in schizophrenia.

Authors:  C N Karson; E Garcia-Rill; J Biedermann; R E Mrak; M M Husain; R D Skinner
Journal:  Psychiatry Res       Date:  1991-05       Impact factor: 3.222

6.  Serotonergic synaptic input to cholinergic neurons in the rat mesopontine tegmentum.

Authors:  T Honda; K Semba
Journal:  Brain Res       Date:  1994-06-06       Impact factor: 3.252

7.  Disinhibition of the sleep state-dependent p1 potential in Parkinson's disease-improvement after pallidotomy.

Authors:  C Teo; L Rasco; R D Skinner; E Garcia-Rill
Journal:  Sleep Res Online       Date:  1998

8.  Pedunculopontine nucleus stimulation improves akinesia in a Parkinsonian monkey.

Authors:  Ned Jenkinson; Dipankar Nandi; R Chris Miall; John F Stein; Tipu Z Aziz
Journal:  Neuroreport       Date:  2004-12-03       Impact factor: 1.837

9.  Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy.

Authors:  E C Hirsch; A M Graybiel; C Duyckaerts; F Javoy-Agid
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

10.  The pedunculopontine nucleus in Parkinson's disease: primate studies.

Authors:  D Nandi; N Jenkinson; J Stein; T Aziz
Journal:  Br J Neurosurg       Date:  2008       Impact factor: 1.596

View more
  12 in total

Review 1.  Basal ganglia, movement disorders and deep brain stimulation: advances made through non-human primate research.

Authors:  Thomas Wichmann; Hagai Bergman; Mahlon R DeLong
Journal:  J Neural Transm (Vienna)       Date:  2017-06-10       Impact factor: 3.575

2.  Optogenetic stimulation of glutamatergic neurons in the cuneiform nucleus controls locomotion in a mouse model of Parkinson's disease.

Authors:  Maxime Fougère; Cornelis Immanuel van der Zouwen; Joël Boutin; Kloé Neszvecsko; Philippe Sarret; Dimitri Ryczko
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-26       Impact factor: 11.205

3.  Effect of MK-801, an antagonist of NMDA receptor in the pedunculopontine tegmental nucleus, on cardiovascular parameters in normotensive and hydralazine hypotensive rats.

Authors:  Mohammad Reza Hosseiniravesh; Vida Hojati; Abolfazl Khajavirad; Hooman Shajiee; Mohammad Naser Shafei; Reza Mohebbati
Journal:  Iran J Basic Med Sci       Date:  2022-05       Impact factor: 2.532

Review 4.  Dopamine and the Brainstem Locomotor Networks: From Lamprey to Human.

Authors:  Dimitri Ryczko; Réjean Dubuc
Journal:  Front Neurosci       Date:  2017-05-26       Impact factor: 4.677

Review 5.  Deep brain stimulation: current challenges and future directions.

Authors:  Andres M Lozano; Nir Lipsman; Hagai Bergman; Peter Brown; Stephan Chabardes; Jin Woo Chang; Keith Matthews; Cameron C McIntyre; Thomas E Schlaepfer; Michael Schulder; Yasin Temel; Jens Volkmann; Joachim K Krauss
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

Review 6.  A Review of the Pedunculopontine Nucleus in Parkinson's Disease.

Authors:  Isobel T French; Kalai A Muthusamy
Journal:  Front Aging Neurosci       Date:  2018-04-26       Impact factor: 5.750

7.  Stereological Estimates of Glutamatergic, GABAergic, and Cholinergic Neurons in the Pedunculopontine and Laterodorsal Tegmental Nuclei in the Rat.

Authors:  Esther Luquin; Ibone Huerta; María S Aymerich; Elisa Mengual
Journal:  Front Neuroanat       Date:  2018-05-11       Impact factor: 3.856

8.  Balance control systems in Parkinson's disease and the impact of pedunculopontine area stimulation.

Authors:  Thushara Perera; Joy L Tan; Michael H Cole; Shivy A C Yohanandan; Paul Silberstein; Raymond Cook; Richard Peppard; Tipu Aziz; Terry Coyne; Peter Brown; Peter A Silburn; Wesley Thevathasan
Journal:  Brain       Date:  2018-10-01       Impact factor: 13.501

9.  Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson's disease.

Authors:  Haidar S Dafsari; K Ray-Chaudhuri; Keyoumars Ashkan; Lena Sachse; Picabo Mahlstedt; Monty Silverdale; Alexandra Rizos; Marian Strack; Stefanie T Jost; Paul Reker; Michael Samuel; Veerle Visser-Vandewalle; Julian Evans; Angelo Antonini; Pablo Martinez-Martin; Lars Timmermann
Journal:  J Neurol       Date:  2020-03-09       Impact factor: 4.849

10.  Proceedings of the Seventh Annual Deep Brain Stimulation Think Tank: Advances in Neurophysiology, Adaptive DBS, Virtual Reality, Neuroethics and Technology.

Authors:  Adolfo Ramirez-Zamora; James Giordano; Aysegul Gunduz; Jose Alcantara; Jackson N Cagle; Stephanie Cernera; Parker Difuntorum; Robert S Eisinger; Julieth Gomez; Sarah Long; Brandon Parks; Joshua K Wong; Shannon Chiu; Bhavana Patel; Warren M Grill; Harrison C Walker; Simon J Little; Ro'ee Gilron; Gerd Tinkhauser; Wesley Thevathasan; Nicholas C Sinclair; Andres M Lozano; Thomas Foltynie; Alfonso Fasano; Sameer A Sheth; Katherine Scangos; Terence D Sanger; Jonathan Miller; Audrey C Brumback; Priya Rajasethupathy; Cameron McIntyre; Leslie Schlachter; Nanthia Suthana; Cynthia Kubu; Lauren R Sankary; Karen Herrera-Ferrá; Steven Goetz; Binith Cheeran; G Karl Steinke; Christopher Hess; Leonardo Almeida; Wissam Deeb; Kelly D Foote; Michael S Okun
Journal:  Front Hum Neurosci       Date:  2020-03-27       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.